Table 1. Demographic and clinical characteristics of participants^* (N = 11) in a nursing home cohort—Georgia, October 2020‒April 2021.

Characteristic	Participants
Age, median [range] in years	74 [37–90]
	n	%
Male	7	64
White	7	64
Black	4	36
Non-Hispanic/Latino	11	100
Underlying conditions †
≥3 underlying conditions	10	91
Cardiovascular disease	11	100
Hypertension	10	91
Coronary artery disease	6	55
Hyperlipidemia	3	27
Heart failure	3	27
Cerebrovascular accident	4	36
Diabetes mellitus	6	55
Chronic kidney disease	3	27
Chronic obstructive pulmonary disease	3	37
Neurologic disease	2	18
Cancer‡	2	18
Former/current smoker	10	91
Severity of illness §
Mild to moderate disease	7	64
Severe disease	4	36
COVID-19 symptom status ||
Symptomatic	9	82
Asymptomatic	2	18
Clinical outcome
Hospitalized	4	36
Died	1	9

* Participants were identified among the cohort of nursing home residents if they were medically stable, had decision-making capacity, and provided informed consent after testing SARS-CoV-2–positive using BinaxNOW^™ COVID-19 Ag Cards in any of three rounds of facility-wide point prevalence surveys conducted by Centers for Disease Control and Prevention staff during late October to early November 2020.

^† None of the participants had hepatic disease as an underlying condition.

^‡ One participant had unspecified B-cell lymphoma and one participant had a malignant neoplasm of colon, per medical record review.

^§ Mild illness was defined as having signs or symptoms without dyspnea or evidence of lower respiratory tract involvement, moderate illness included signs of lower respiratory disease by clinical assessment or imaging, and severe disease was tachypnea (>30 breaths per minute), oxygen saturation < 90% (or decrease from baseline over 3%), hospitalization, or death. Asymptomatic participants were considered to have mild illness.

^|| Symptoms represent the earliest reported COVID-19 symptoms from 14 days prior to facility-wide CDC testing through the end of the evaluation period.